Retraction: Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1/CCNB1/PLK1 signaling

Retraction: Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1/CCNB1/PLK1 signaling

Saved in:

Bibliographic Details
Main Author:	Frontiers Editorial Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Oncology
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1591122/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RETRACTED: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
by: You-Cai Yi, et al.
Published: (2021-11-01)

Mitotic Kinases Aurora-A, Plk1, and Cdk1 Interact with Elk-1 Transcription Factor through the N-Terminal Domain
by: Oya Arı Uyar, et al.
Published: (2024-01-01)

Expression of FOXM1 and PLK1 in Colorectal Cancer and Their Relationship with Clinicopathological Features and Prognosis
by: Xue HAN, et al.
Published: (2025-07-01)

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1
by: Yalei Wen, et al.
Published: (2025-03-01)

CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer
by: Hatice Sevim Nalkiran, et al.
Published: (2024-12-01)

Cited1 deficiency suppresses intestinal tumorigenesis.
by: Valérie Méniel, et al.
Published: (2013-01-01)

Dynamic Mitotic Localization of the Centrosomal Kinases CDK1, Plk, AurK, and Nek2 in <i>Dictyostelium amoebae</i>
by: Stefan Krüger, et al.
Published: (2024-09-01)

Self-priming of Plk1 binding to BubR1 ensures accurate mitotic progression
by: Chunlin Song, et al.
Published: (2024-11-01)

Retraction: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
by: Frontiers Editorial Office
Published: (2024-12-01)

Retraction: Erratum: High glucose induced HIF-1α/TREK1 expression and myometrium relaxation during pregnancy
by: Frontiers Editorial Office
Published: (2025-03-01)

PLK1 inhibition impairs erythroid differentiation
by: Peijun Jia, et al.
Published: (2024-12-01)

SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming
by: Xin Jin, et al.
Published: (2025-07-01)

Retraction: EZH2-mediated microRNA-375 upregulation promotes progression of breast cancer via the inhibition of FOXO1 and the p53 signaling pathway
by: Frontiers Editorial Office
Published: (2025-07-01)

Ropivacaine-loaded tumor-derived vesicles targeting CCNB1 and autophagy in nasopharyngeal carcinoma
by: Xue Zhang, et al.
Published: (2025-10-01)

Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle
by: Lin Li, et al.
Published: (2025-02-01)

Retraction: Zeng et al. Silencing NEAT1 suppresses thyroid carcinoma via miR-126/NEAT1/VEGFA axis. Frontiers in Bioscience (Landmark Edition). 2020; 25: 564–576.
by: Frontiers in Bioscience-Landmark Editorial Office null
Published: (2024-12-01)

TLN1: an oncogene associated with tumorigenesis and progression
by: Sixin Li, et al.
Published: (2024-11-01)

Retraction: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach
by: Frontiers Editorial Office
Published: (2025-04-01)

Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway
by: Frontiers Editorial Office
Published: (2025-06-01)

The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
by: Ron Firestein, et al.
Published: (2008-04-01)

Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1
by: Kun Qiao, et al.
Published: (2025-02-01)

Ezetimibe Engineered L14‐8 Suppresses Advanced Prostate Cancer by Activating PLK1/TP53‐SAT1‐Induced Ferroptosis
by: Yu Zhang, et al.
Published: (2025-08-01)

USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC
by: Xuezhi Du, et al.
Published: (2025-06-01)

RETRACTED: Erratum: High glucose induced HIF-1α/TREK1 expression and myometrium relaxation during pregnancy
by: Frontiers Production Office
Published: (2023-04-01)

Retraction: Polyphenolic fraction obtained from Thalassia testudinum marine plant and thalassiolin B exert cytotoxic effects in colorectal cancer cells and arrest tumor progression in a xenograft mouse model
by: Frontiers Editorial Office
Published: (2025-06-01)

The <i>plk1</i> Gene Regulatory Network Modeling Identifies Three Circuits for <i>plk1</i>-mediated Genomic Instability Leading to Neoplastic Transformation
by: Jeison F. Suescum-Holguín, et al.
Published: (2025-05-01)

M7: A novel in vitro CDK1 inhibitor suppressing colorectal cancer cell proliferation, migration and promoting apoptosis
by: Lihong Yang, et al.
Published: (2025-08-01)

Molecular and genetic evidence for the role of AMBRA1 in suppressing S-phase entry and tumorigenesis
by: Hisako Akatsuka, et al.
Published: (2025-08-01)

Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study
by: Zhilan Zhang, et al.
Published: (2025-03-01)

Retraction: Histone methyltransferase SETD1A induces epithelial-mesenchymal transition to promote invasion and metastasis through epigenetic reprogramming of snail in gastric cancer
by: Frontiers Editorial Office
Published: (2025-06-01)

Retraction: Eupalinolide J suppresses the growth of triple-negative breast cancer cells via targeting STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2025-06-01)

Retraction: A matrine derivative M54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein S5
by: Frontiers Editorial Office
Published: (2025-02-01)

PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1
by: Xingyu Peng, et al.
Published: (2025-06-01)

CDK1-mediated phosphorylation of USP37 regulates SND1 stability and promotes oncogenesis in colorectal cancer
by: Liang Wu, et al.
Published: (2025-04-01)

Pharmacological inhibition of PLK1/PRC1 triggers mitotic catastrophe and sensitizes lung cancers to chemotherapy
by: Pingping Li, et al.
Published: (2025-05-01)

Retraction: Corrigendum: A matrine derivative M54 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by targeting ribosomal protein S5
by: Frontiers Editorial Office
Published: (2025-02-01)

MicroRNA‐125a inhibits tumorigenesis by targeting Smurf1 in colorectal carcinoma
by: Dongbin Li, et al.
Published: (2019-07-01)

Optochemical control of G1 cell cycle by regulating CDK4/6 degradation
by: Tianyi Wang, et al.
Published: (2025-09-01)

Retraction: USP22 protects against myocardial ischemia–reperfusion injury via the SIRT1-p53/SLC7A11–dependent inhibition of ferroptosis–induced cardiomyocyte death
by: Frontiers Editorial Office
Published: (2025-06-01)

High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1
by: Yang Xia, et al.
Published: (2025-12-01)